A.S.P.E.N. clinical guidelines: nutrition support of neonatal patients at risk for metabolic bone disease.
JPEN J Parenter Enteral Nutr
; 37(5): 570-98, 2013 Sep.
Article
em En
| MEDLINE
| ID: mdl-23685349
ABSTRACT
BACKGROUND:
Premature infants are at increased risk for metabolic bone disease, with resulting delayed bone growth, osteopenia, and rickets.METHOD:
A systematic review of the best available evidence to answer a series of questions regarding neonatal patients at risk of metabolic bone disease receiving parenteral or enteral nutrition was undertaken and evaluated using concepts adopted from the Grading of Recommendations, Assessment, Development and Evaluation working group. A consensus process was used to develop the clinical guideline recommendations prior to external and internal review and approval by the American Society for Parenteral and Enteral Nutrition Board of Directors. QUESTIONS (1) What maternal risk factors predispose the neonate to metabolic bone disease? (2) What is the optimal type of feeding to promote neonatal bone health? (3) When and how should vitamin D supplements be administered? (4) Does parenteral nutrition (PN) predispose a neonate to metabolic bone disease, and if so, are there PN formulation recommendations to minimize this risk?Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Doenças Ósseas Metabólicas
/
Recém-Nascido Prematuro
/
Apoio Nutricional
Tipo de estudo:
Etiology_studies
/
Guideline
/
Observational_studies
/
Risk_factors_studies
/
Systematic_reviews
Idioma:
En
Revista:
JPEN J Parenter Enteral Nutr
Ano de publicação:
2013
Tipo de documento:
Article
País de afiliação:
Estados Unidos